Propelled by rising investments, increasing M&A activities and collaboration, and rapid technological advancements, the biotechnology market is experiencing robust growth and expansion. Further, as the biotech industry evolves, its scope and scale expand to open new opportunities, strongly favoring its prospects.
Considering the industry’s bright outlook, it could be wise to invest in innovative biotech stocks Regeneron Pharmaceuticals, Inc. (REGN), Biogen Inc. (BIIB), and Gilead Sciences Inc. (GILD) for potential gains.
